论文部分内容阅读
到目前为止,沪深两地股票市场的制药行业上市公司总数已达到30家,约占上市公司总数的4.1%。根据医药行业1997中期财务报表,对其经营情况进行如下分析: 一、沪深制药行业上市公司综合分析 1.从主要收入指标和利润指标来看,制药行业的上市公司平均主营收入为22150万元,平均主营利润为2523万元。主营业务收入排在前两位的公司是华北制药和东北制药这两大制药行业巨头。主营收入分别为75540万元和50941万元。主营收入最少的是湘中药,为
So far, the total number of pharmaceutical industry listed companies in the stock markets of Shanghai and Shenzhen has reached 30, accounting for about 4.1% of the total number of listed companies. According to the interim financial statements of the pharmaceutical industry in 1997, the following analysis of its operation: First, a comprehensive analysis of listed companies in Shanghai and Shenzhen Pharmaceutical Industry 1. From the main income indicators and profit indicators, the pharmaceutical industry’s average main income of listed companies was 221.5 million Yuan, the average main profit of 25230000 yuan. The top two companies whose main business income ranks are the big pharmaceutical industry giants such as North China Pharmaceutical and Tohoku Pharmaceutical. Main income was 755.4 million yuan and 504.41 million yuan. The main income is the least Hunan medicine,